Tagged: malaria

Update from the Dean - March 2017

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication management; Medicare Part D as a learning model for pharmacy education—impact 10 years out; New genetic insights into diabetes drug response; Annotating the ‘dark genome’; Epigenetics of ethnicity; New endowed professorships made possible by private support; New Center for Cellular Construction; Major funding for UCSF-Stanford CERSI; 2017 Mary Anne Koda-Kimble Seed Award for Innovation; Welcoming the class of 2020; Three generations at the School of Pharmacy; Developing a curriculum for 2018 and beyond; AFPE honors Frank Szoka as Mentor of the Year; 2016 Chancellor Diversity Awards honor Marcus Ferrone and Peace Chukudi; Eddie Way celebrates 100 years; CPhA Hall of Fame honors Brian Komoto, Phillip Oppenheimer, Wilma Wong; $500M gift to campus from Helen Diller Foundation; UC statement on federal executive order restricting travel and entry.

Renewed funding for Aweeka study on malaria treatment for children with HIV in Africa

Fran Aweeka, PharmD, will receive renewed funding for her grant from the National Institutes of Health for evaluating the pharmacology of antimalarial drugs in children in Africa. This is a renewal of her R01 on this important work, and will provide five years of funding for Dr. Aweeka and her colleagues at Yale and in Uganda.

Aweeka study details impact of HIV drugs on malaria treatment in children

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Nancy Sambol, PharmD

Associate Professor

I focus on the use of models to describe drug disposition and effect in patient populations, and the use of these models to make predictions to improve drug therapy.

New NIH funding awarded to the Department of Clinical Pharmacy in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:

New NIH funding awarded to the Department of Pharmaceutical Chemistry in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry: